Oct 22, 2019
GT Biopharma Announces Solid Tumor Targeting TriKe(TM) Kills Non-small Cell Lung Cancer (NSCLC) Tumor Cells
Oct 03, 2019
GT Biopharma Announces HIV TriKE(TM) Data Demonstrating NK Cell Killing of Patient HIV Infected Cells
Sep 26, 2019
GT Biopharma Announces HIV Trike(TM) Data to be Published
Sep 24, 2019
GT Biopharma Announces the Sale of Its Fixed Dose Combination Tablet (GTB-004) for Myasthenia Gravis (Chronic Autoimmune Disease) to DAS Therapeutics
Sep 12, 2019
GT Biopharma Announces FDA Notification of Commencement of Enrollment in Human GTB-3550 Trike(TM) Phase i/ii Clinical Trial
Jun 10, 2019
GT Biopharma Company Update
May 30, 2019
GT Biopharma GTB-1550 Clinical Development Update
May 29, 2019
GT Biopharma GTB-1550 PHASE I-II Results to be Published in Conjunction With 2019 ASCO Meeting May 31 - June 4 in Chicago
Apr 25, 2019
GT Biopharma (GTBP) to Broadcast Update on TriKE Initiatives for HIV and Oncology at University of Minnesota On May 7th; Dr. Jeff Miller And Dr. Timothy Schacker to Host Event
Apr 24, 2019
GT Biopharma (GTBP) Announces the Elimination of HIV Infected Cells Using its Tri-Specific Killer Engagers (TriKEs) in Preclinical Testing at the University of Minnesota
Apr 08, 2019
GT Biopharma Receives Institutional Review Board Approval to Proceed With in Human FDA Phase 1 Clinical Trial
Mar 26, 2019
GT Biopharma Announces Completion of Management Restructuring
Aug 30, 2018
GT Biopharma's Chairman and Chief Executive Officer Raymond W Urbanski, M.D., Ph.D Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration
Aug 29, 2018
GT Biopharma's Chairman and Chief Executive Officer Provides Insight Into the Impact of the Recent Affimed/Roche-Genetech Collaboration
Aug 28, 2018
GT Biopharma Announces Initiation of OXS-1550 in Combination With a Multi-billion Dollar Oncology Drug
Aug 24, 2018
GT Biopharma Announces the Appointment of David Cardino, CPA, MBA as Vice President of Finance
Aug 14, 2018
GT Biopharma Announces GTBP CEO, Dr. Raymond Urbanski, to Make Presentation at the 2018 Wedbush PacGrow Healthcare Conference
Jul 25, 2018
GT Biopharma Announces the Addition of Dr. John N. Bonfiglio to its Board of Directors
Jul 19, 2018
GT Biopharma Inc. Announces Agreement with a Major Pharmaceutical Company to Study its Drug Candidate OXS-1550 in Combination With a Multi-Billion Dollar Oncology Drug
Jun 05, 2018
GT Biopharma Announces Voluntary Lock-Up Agreements With Insiders Covering Over 52% of Outstanding Shares